Theravance Biopharma Inc (TBPH)
EBITDA Margin
65.84%
TTM · Period ending:
TBPH EBITDA Margin
Latest reported65.84%period ending
Latest reported65.84%period ending
TBPH EBITDA Margin (-710.19% → 65.84%)
Annual ebitda margin
High-resolution chart · PNG
TBPH ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 127.6921% | |
| -59.7272% | |
| -86.0146% | |
| -140.4102% | |
| -414.1021% | |
| -400.5511% | |
| -277.3327% | |
| -351.8917% | |
| -1,684.2389% | |
| -361.8566% | |
| -424.365% | |
| -1,950.8214% | |
| -67,978.3186% | |
| -4.8592% | |
| -710.1858% |